MannKind Corp
MNKD
#5739
Rank
S$1.59 B
Marketcap
S$4.97
Share price
-2.53%
Change (1 day)
-24.02%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -S$62.63 Million

According to MannKind Corp's latest financial reports the company's current earnings are S$0.39 Billion. In 2025 the company made an earning of S$1.81 Million a decrease over its 2024 earnings that were of S$39.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$62.63 Million-3550.14%
2025 S$1.81 M-95.39%
2024 S$39.36 M-394.09%
2023 -S$13.39 Million-88.13%
2022 -S$0.12 Billion8%
2021 -S$0.11 Billion40.84%
2020 -S$74.13 Million10.7%
2019 -S$66.96 Million-40.16%
2018 -S$0.12 Billion-26.04%
2017 -S$0.16 Billion-193.33%
2016 S$0.16 B-134.11%
2015 -S$0.48 Billion85.72%
2014 -S$0.26 Billion3.6%
2013 -S$0.25 Billion12.79%
2012 -S$0.22 Billion5.58%
2011 -S$0.21 Billion-5.72%
2010 -S$0.23 Billion-22.51%
2009 -S$0.29 Billion-27.37%
2008 -S$0.4 Billion3.36%
2007 -S$0.38 Billion27.18%
2006 -S$0.3 Billion101.63%
2005 -S$0.15 Billion50.46%
2004 -S$98.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.98 B-14,421.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$29.64 B-47,339.69%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
S$44.85 B-71,562.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B-13,917.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
S$0.75 B-1,298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-S$0.2 Billion 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA